Results 81 to 90 of about 392 (96)
Some of the next articles are maybe not open access.

Seizures and Movement Disorders in Patients with CLN2 Disease Treated with Cerliponase Alfa in the Real-World Setting

Neuropediatrics
Angela Schulz   +10 more
openaire   +1 more source

Brainstem auditory evoked potentials (BAEP) in CLN2 patients under treatment with cerliponase alfa

Molecular Genetics and Metabolism
Christoph Schwering   +2 more
openaire   +1 more source

Cerliponase Alfa: First Global Approval

Drugs, 2017
Markham Anthony, Anthony Markham
exaly  

Cerliponase alfa for the treatment of CLN2 disease in a patient cohort including children under 3 years of age

Molecular Genetics and Metabolism
Angela Schulz   +6 more
openaire   +1 more source

Presymptomatic and symptomatic disease stage-dependent outcomes of cerliponase alfa treatment in siblings with CLN2 disease

Molecular Genetics and Metabolism
Lena Marie Westermann   +8 more
openaire   +1 more source

A long-term observation of ophthalmology assessment in atypical CLN2 patients receiving ICV cerliponase alfa treatment

Molecular Genetics and Metabolism
Audrey Kao   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy